The University of Utah has been awarded a $654,105 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." The three-year grant, awarded on June 1, 2024, will support the university's cutting-edge research aimed at improving health outcomes for military service members, veterans, and the broader public. The research will leverage the university's expertise in biomedical sciences and digital pathology to develop innovative predictive models for prostate cancer treatment response, ultimately contributing to advancements in military medical research.
Generated 3/4/25, 2:02 AM